{"nct_id":"NCT03374488","title":"Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2017-12-22","start_date_type":"ACTUAL","primary_completion_date":"2018-07-27","primary_completion_date_type":"ACTUAL","completion_date":"2020-07-23","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["INCY"]}